mRNA Vaccine Technology Beyond COVID-19
Background/Objectives: Since their approval in early 2020, mRNA vaccines have gained significant attention since the COVID-19 pandemic as a potential therapeutic approach to tackle several infectious diseases. This article aims to review the current state of mRNA vaccine technology and its use again...
Saved in:
Main Authors: | Sola Oloruntimehin, Florence Akinyi, Michael Paul, Olumuyiwa Ariyo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/6/601 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Systematic Review of Clinical Trials Using mRNA Vaccines for Infectious Diseases other than COVID-19
by: Athina Sofroniou, et al.
Published: (2025-07-01) -
Nanoparticle-Based mRNA Vaccine Induces Protective Neutralizing Antibodies Against Infectious Bronchitis Virus in In-Vivo Infection
by: Aseno Sakhrie, et al.
Published: (2025-05-01) -
Research progress on the quality control of mRNA vaccines
by: Chaoying Hu, et al.
Published: (2024-12-01) -
Pre-Vaccination Immune Profiles and Responsiveness to Innate Stimuli Predict Reactogenicity and Antibody Magnitude Following mRNA Vaccination
by: Amanda E. Zelkoski, et al.
Published: (2025-07-01) -
Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus
by: Buyani Ndlovu, et al.
Published: (2025-07-01)